Abstract
Objectives:
This study aimed to describe our experience with pediatric bacterial pericarditis and review the optimal therapy for this entity.
Methods:
This is a retrospective study in a pediatric intensive care unit in a university hospital. Three children were diagnosed with purulent pericarditis. They were all treated with antibiotics, echocardiography-guided pericardial fluid drainage, and placement of a pericardial catheter, with no need for thoracotomy or pericardial window.
Results:
All 3 children fully recovered, and none developed constrictive pericarditis.
Conclusions:
Children with purulent pericarditis usually can be treated with antibiotics and drainage of pericardial effusion, with no need for thoracotomy or pericardial window.
MeSH terms
-
Anti-Bacterial Agents / therapeutic use*
-
Cardiac Tamponade / diagnostic imaging
-
Cardiac Tamponade / etiology
-
Catheterization / methods*
-
Child, Preschool
-
Combined Modality Therapy
-
Drainage / methods*
-
Emergencies
-
Female
-
Humans
-
Infant
-
Intensive Care Units, Pediatric
-
Pericardiectomy*
-
Pericardiocentesis*
-
Pericarditis / drug therapy
-
Pericarditis / surgery*
-
Pericarditis, Constrictive / prevention & control
-
Pneumococcal Infections / complications
-
Pneumococcal Infections / diagnosis
-
Pneumococcal Infections / drug therapy
-
Pneumococcal Infections / surgery
-
Retrospective Studies
-
Staphylococcal Infections / complications*
-
Staphylococcal Infections / diagnosis
-
Staphylococcal Infections / drug therapy
-
Staphylococcal Infections / surgery
-
Streptococcal Infections / complications*
-
Streptococcal Infections / diagnosis
-
Streptococcal Infections / drug therapy
-
Streptococcal Infections / surgery
-
Streptococcus pyogenes / isolation & purification*
-
Suppuration
-
Ultrasonography, Interventional
-
Unnecessary Procedures*
-
Urokinase-Type Plasminogen Activator / administration & dosage
-
Urokinase-Type Plasminogen Activator / therapeutic use
Substances
-
Anti-Bacterial Agents
-
Urokinase-Type Plasminogen Activator